Medicare’s National Coverage Determination for Aducanumab — A One-Off or a Pragmatic Path Forward?
Dhruva SS, Ramachandran R, Ross JS. Medicare’s National Coverage Determination for Aducanumab — A One-Off or a Pragmatic Path Forward? New England Journal Of Medicine 2022, 387: 1539-1541. PMID: 36301560, DOI: 10.1056/nejmp2210198.Commentaries, Editorials and LettersConceptsNational Coverage DeterminationMedicare National Coverage DeterminationCoverage determinationAducanumab